🇺🇸 FDA
Patent

US 7744902

Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7744902 (Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/543, A61K2039/545